Quick Answer
PURPLE BIOTECH LTD. reported R&D Expense of $3.73 million for fiscal year 2025.
PURPLE BIOTECH LTD. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $3.73M | -51.0% |
| 2024 | $7.62M | -55.3% |
| 2023 | $17.03M | +4.4% |
| 2022 | $16.32M | +38.0% |
| 2021 | $11.83M | +63.4% |
| 2020 | $7.24M | +217.7% |
| 2019 | $2.28M | -56.8% |
| 2018 | $5.27M | +13.5% |
| 2017 | $4.64M | +11.0% |
| 2016 | $4.18M | +63.3% |
| 2015 | $2.56M | — |
- PURPLE BIOTECH LTD. showed a decrease of -51.0% in R&D Expense compared to the prior fiscal year.
- Over the 2015–2025 period, PURPLE BIOTECH LTD.’s r&d expense has grown by 45.7% (from $2.56 million to $3.73 million).
- The most recent figure is from PURPLE BIOTECH LTD.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: